Description

4H-Quinolizin-4-One,2,3,6,7,8,9-Hexahydro-(9Ci) is a complex heterocyclic organic compound that serves as a versatile and valuable synthetic intermediate. Its unique fused ring structure makes it a critical building block for the development of novel pharmacologically active molecules and advanced materials. This high-purity intermediate is primarily sought by research institutions and industrial R&D departments in the pharmaceutical, agrochemical, and specialty chemical sectors for constructing complex molecular architectures.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly for central nervous system (CNS) agents, anti-infectives, and other bioactive heterocycles.
• Agrochemical Research: Used in the development of new pesticides and herbicides, where its quinolizine core can contribute to unique modes of action.
• Material Science: Serves as a building block for organic electronic materials, such as charge-transport layers or light-emitting components, due to its conjugated system potential.
• Chemical Synthesis: Employed in academic and industrial organic chemistry research for methodology development and the construction of complex natural product analogs.
• Ligand & Catalyst Development: Its nitrogen-containing structure makes it a candidate for developing novel chelating ligands and organocatalysts.

Basic Information

Product Name	4H-Quinolizin-4-One,2,3,6,7,8,9-Hexahydro-(9Ci)
CAS No.	480445-27-0
Molecular Formula	C9H11NO
Molecular Weight	149.19 g/mol
Synonyms	2,3,6,7,8,9-Hexahydro-4H-quinolizin-4-one; Octahydro-4-quinolizinone; 4-Quinolizinone, 2,3,6,7,8,9-hexahydro-; 4H-Quinolizin-4-one, octahydro-; 1-Azabicyclo[3.3.1]nonan-9-one; 9-Azabicyclo[3.3.1]nonan-3-one (tautomeric form); Bicyclic lactam intermediate
EINECS	Contact for details

Quality Control

Our 4H-Quinolizin-4-One,2,3,6,7,8,9-Hexahydro-(9Ci) is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity for research and development applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We support cGMP (current Good Manufacturing Practice) standards for advanced intermediates intended for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Keep away from incompatible materials such as strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 97.0% (Area %)
Water Content (KF)	≤ 0.5% w/w
Residue on Ignition	≤ 0.1%
Heavy Metals (as Pb)	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.